Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
or

Hims & Hers Health Inc (HIMS)

Hims & Hers Health Inc (HIMS)
33.13 x 3 33.20 x 3
Pre-market by (Cboe BZX)
33.36 -3.68 (-9.94%) 03/26/25 [NYSE]
33.13 x 3 33.20 x 3
Pre-market 33.19 -0.17 (-0.51%) 04:15 ET
Quote Overview for Wed, Mar 26th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
35.77
Day High
38.69
Open 37.82
Previous Close 37.04 37.04
Volume 17,428,600 17,428,600
Avg Vol 24,338,125 24,338,125
Stochastic %K 57.06% 57.06%
Weighted Alpha +43.12 +43.12
5-Day Change -0.52 (-1.53%) -0.52 (-1.53%)
52-Week Range 11.20 - 72.98 11.20 - 72.98
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,229,029
  • Shares Outstanding, K 222,166
  • Annual Sales, $ 1,477 M
  • Annual Income, $ 126,040 K
  • EBIT $ 62 M
  • EBITDA $ 75 M
  • 60-Month Beta 1.37
  • Price/Sales 5.63
  • Price/Cash Flow 106.23
  • Price/Book 17.33

Options Overview Details

View History
  • Implied Volatility 90.79% ( +6.65%)
  • Historical Volatility 170.10%
  • IV Percentile 54%
  • IV Rank 43.17%
  • IV High 144.96% on 02/21/25
  • IV Low 49.65% on 05/10/24
  • Put/Call Vol Ratio 0.89
  • Today's Volume 98,039
  • Volume Avg (30-Day) 96,270
  • Put/Call OI Ratio 0.82
  • Today's Open Interest 515,815
  • Open Int (30-Day) 633,172

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.11
  • Number of Estimates 6
  • High Estimate 0.15
  • Low Estimate 0.06
  • Prior Year 0.05
  • Growth Rate Est. (year over year) +120.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
31.01 +7.58%
on 03/13/25
Period Open: 41.89
46.35 -28.02%
on 03/03/25
-8.53 (-20.36%)
since 02/26/25
3-Month
24.07 +38.60%
on 01/10/25
Period Open: 28.49
72.98 -54.29%
on 02/19/25
+4.87 (+17.09%)
since 12/26/24
52-Week
11.20 +197.86%
on 05/03/24
Period Open: 15.82
72.98 -54.29%
on 02/19/25
+17.54 (+110.87%)
since 03/26/24

Most Recent Stories

More News
Why Novo Nordisk Stock Dropped on Monday, but Eli Lilly and Him & Hers Health Popped

There's a price war brewing in GLP-1 weight loss drugs, and now it's going global.

NVO : 71.73 (-2.54%)
HIMS : 33.36 (-9.94%)
LLY : 826.76 (-3.00%)
Why Hims & Hers Health (HIMS) Shares Are Trading Lower Today

Why Hims & Hers Health (HIMS) Shares Are Trading Lower Today

HIMS : 33.36 (-9.94%)
Why Hims & Hers Stock Tumbled on Tuesday

Bank of America just delivered an incredibly back-handed compliment to Hims & Hers stock.

BAC : 42.82 (-1.06%)
HIMS : 33.36 (-9.94%)
2 Healthcare Stocks with Solid Fundamentals and 1 to Brush Off

2 Healthcare Stocks with Solid Fundamentals and 1 to Brush Off

CHE : 609.17 (-0.02%)
HIMS : 33.36 (-9.94%)
UTHR : 310.82 (-1.87%)
Is Viking Therapeutics the Next Blockbuster GLP-1 Stock?

Viking Therapeutic may have a GLP-1 blockbuster on their hands with VK2735 as it produces weight loss at 5X the speed of Novo Nordisk's Wegovy GLP-1 drug.

VKTX : 26.34 (-5.86%)
NVO : 71.73 (-2.54%)
HIMS : 33.36 (-9.94%)
LLY : 826.76 (-3.00%)
Why Hims & Hers Stock Popped on Monday

Morgan Stanley had great news for Hims & Hers stock today, so why didn't it upgrade the stock?

AAPL : 221.53 (-0.99%)
HIMS : 33.36 (-9.94%)
NVO : 71.73 (-2.54%)
MS : 122.20 (-2.40%)
LLY : 826.76 (-3.00%)
2 High-Flying Stocks with Exciting Potential and 1 to Turn Down

2 High-Flying Stocks with Exciting Potential and 1 to Turn Down

EXPO : 80.41 (+0.45%)
HIMS : 33.36 (-9.94%)
RSG : 237.75 (-0.02%)
Why Hims & Hers Health Stock Just Popped

Roller-coaster healthcare stock Hims & Hers Health (NYSE: HIMS), whose stock got devastated last week by worries that it would be shut out of the GLP-1 market, got a reprieve from the Food and Drug Administration...

HIMS : 33.36 (-9.94%)
NVO : 71.73 (-2.54%)
LLY : 826.76 (-3.00%)
4 Top Stocks to Buy Under $100

Here are four stocks to buy now that could offer investors upside in the short and long terms.

TTD : 58.80 (-5.16%)
HIMS : 33.36 (-9.94%)
UBER : 74.18 (-1.89%)
HOOD : 44.73 (-7.10%)
Should You Buy Hims & Hers Stock on the Dip?

Hims & Hers (NYSE: HIMS) is taking investors on a roller-coaster ride in 2025.

HIMS : 33.36 (-9.94%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree...

See More

Key Turning Points

3rd Resistance Point 41.15
2nd Resistance Point 39.55
1st Resistance Point 36.45
Last Price 33.36
1st Support Level 31.76
2nd Support Level 30.16
3rd Support Level 27.06

See More

52-Week High 72.98
Fibonacci 61.8% 49.38
Fibonacci 50% 42.09
Fibonacci 38.2% 34.80
Last Price 33.36
52-Week Low 11.20

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies